table of content
1 Introduction to Research & Analysis Reports
1.1 Hemophilia Gene Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hemophilia Gene Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hemophilia Gene Therapy Overall Market Size
2.1 Global Hemophilia Gene Therapy Market Size: 2022 VS 2029
2.2 Global Hemophilia Gene Therapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Hemophilia Gene Therapy Players in Global Market
3.2 Top Global Hemophilia Gene Therapy Companies Ranked by Revenue
3.3 Global Hemophilia Gene Therapy Revenue by Companies
3.4 Top 3 and Top 5 Hemophilia Gene Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Hemophilia Gene Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hemophilia Gene Therapy Players in Global Market
3.6.1 List of Global Tier 1 Hemophilia Gene Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Hemophilia Gene Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Hemophilia Gene Therapy Market Size Markets, 2022 & 2029
4.1.2 Hemophilia A
4.1.3 Hemophilia B
4.2 By Type - Global Hemophilia Gene Therapy Revenue & Forecasts
4.2.1 By Type - Global Hemophilia Gene Therapy Revenue, 2018-2023
4.2.2 By Type - Global Hemophilia Gene Therapy Revenue, 2024-2029
4.2.3 By Type - Global Hemophilia Gene Therapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hemophilia Gene Therapy Market Size, 2022 & 2029
5.1.2 Hemophilia A Gene Therapy
5.1.3 Hemophilia B Gene Therapy
5.2 By Application - Global Hemophilia Gene Therapy Revenue & Forecasts
5.2.1 By Application - Global Hemophilia Gene Therapy Revenue, 2018-2023
5.2.2 By Application - Global Hemophilia Gene Therapy Revenue, 2024-2029
5.2.3 By Application - Global Hemophilia Gene Therapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Hemophilia Gene Therapy Market Size, 2022 & 2029
6.2 By Region - Global Hemophilia Gene Therapy Revenue & Forecasts
6.2.1 By Region - Global Hemophilia Gene Therapy Revenue, 2018-2023
6.2.2 By Region - Global Hemophilia Gene Therapy Revenue, 2024-2029
6.2.3 By Region - Global Hemophilia Gene Therapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Hemophilia Gene Therapy Revenue, 2018-2029
6.3.2 US Hemophilia Gene Therapy Market Size, 2018-2029
6.3.3 Canada Hemophilia Gene Therapy Market Size, 2018-2029
6.3.4 Mexico Hemophilia Gene Therapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Hemophilia Gene Therapy Revenue, 2018-2029
6.4.2 Germany Hemophilia Gene Therapy Market Size, 2018-2029
6.4.3 France Hemophilia Gene Therapy Market Size, 2018-2029
6.4.4 U.K. Hemophilia Gene Therapy Market Size, 2018-2029
6.4.5 Italy Hemophilia Gene Therapy Market Size, 2018-2029
6.4.6 Russia Hemophilia Gene Therapy Market Size, 2018-2029
6.4.7 Nordic Countries Hemophilia Gene Therapy Market Size, 2018-2029
6.4.8 Benelux Hemophilia Gene Therapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Hemophilia Gene Therapy Revenue, 2018-2029
6.5.2 China Hemophilia Gene Therapy Market Size, 2018-2029
6.5.3 Japan Hemophilia Gene Therapy Market Size, 2018-2029
6.5.4 South Korea Hemophilia Gene Therapy Market Size, 2018-2029
6.5.5 Southeast Asia Hemophilia Gene Therapy Market Size, 2018-2029
6.5.6 India Hemophilia Gene Therapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Hemophilia Gene Therapy Revenue, 2018-2029
6.6.2 Brazil Hemophilia Gene Therapy Market Size, 2018-2029
6.6.3 Argentina Hemophilia Gene Therapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Hemophilia Gene Therapy Revenue, 2018-2029
6.7.2 Turkey Hemophilia Gene Therapy Market Size, 2018-2029
6.7.3 Israel Hemophilia Gene Therapy Market Size, 2018-2029
6.7.4 Saudi Arabia Hemophilia Gene Therapy Market Size, 2018-2029
6.7.5 UAE Hemophilia Gene Therapy Market Size, 2018-2029
7 Hemophilia Gene Therapy Companies Profiles
7.1 Spark Therapeutics
7.1.1 Spark Therapeutics Company Summary
7.1.2 Spark Therapeutics Business Overview
7.1.3 Spark Therapeutics Hemophilia Gene Therapy Major Product Offerings
7.1.4 Spark Therapeutics Hemophilia Gene Therapy Revenue in Global Market (2018-2023)
7.1.5 Spark Therapeutics Key News & Latest Developments
7.2 Ultragenyx
7.2.1 Ultragenyx Company Summary
7.2.2 Ultragenyx Business Overview
7.2.3 Ultragenyx Hemophilia Gene Therapy Major Product Offerings
7.2.4 Ultragenyx Hemophilia Gene Therapy Revenue in Global Market (2018-2023)
7.2.5 Ultragenyx Key News & Latest Developments
7.3 Shire PLC
7.3.1 Shire PLC Company Summary
7.3.2 Shire PLC Business Overview
7.3.3 Shire PLC Hemophilia Gene Therapy Major Product Offerings
7.3.4 Shire PLC Hemophilia Gene Therapy Revenue in Global Market (2018-2023)
7.3.5 Shire PLC Key News & Latest Developments
7.4 Sangamo Therapeutics
7.4.1 Sangamo Therapeutics Company Summary
7.4.2 Sangamo Therapeutics Business Overview
7.4.3 Sangamo Therapeutics Hemophilia Gene Therapy Major Product Offerings
7.4.4 Sangamo Therapeutics Hemophilia Gene Therapy Revenue in Global Market (2018-2023)
7.4.5 Sangamo Therapeutics Key News & Latest Developments
7.5 Bioverativ
7.5.1 Bioverativ Company Summary
7.5.2 Bioverativ Business Overview
7.5.3 Bioverativ Hemophilia Gene Therapy Major Product Offerings
7.5.4 Bioverativ Hemophilia Gene Therapy Revenue in Global Market (2018-2023)
7.5.5 Bioverativ Key News & Latest Developments
7.6 BioMarin
7.6.1 BioMarin Company Summary
7.6.2 BioMarin Business Overview
7.6.3 BioMarin Hemophilia Gene Therapy Major Product Offerings
7.6.4 BioMarin Hemophilia Gene Therapy Revenue in Global Market (2018-2023)
7.6.5 BioMarin Key News & Latest Developments
7.7 uniQure
7.7.1 uniQure Company Summary
7.7.2 uniQure Business Overview
7.7.3 uniQure Hemophilia Gene Therapy Major Product Offerings
7.7.4 uniQure Hemophilia Gene Therapy Revenue in Global Market (2018-2023)
7.7.5 uniQure Key News & Latest Developments
7.8 Freeline Therapeutics
7.8.1 Freeline Therapeutics Company Summary
7.8.2 Freeline Therapeutics Business Overview
7.8.3 Freeline Therapeutics Hemophilia Gene Therapy Major Product Offerings
7.8.4 Freeline Therapeutics Hemophilia Gene Therapy Revenue in Global Market (2018-2023)
7.8.5 Freeline Therapeutics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
